oncotarget: metronomic cyclophosphamide - innate immunity and anti-tumor responses
Published 4 years ago • 708 plays • Length 11:17Download video MP4
Download video MP3
Similar videos
-
6:52
oncotarget: targeting mesothelin with high cytotoxic activity
-
0:57
oncotarget: t-cell-targeted immunotherapy for recurrent hnscc
-
0:53
oncotarget: akt antagonist drug and th1 cytokines combat breast cancer
-
2:06
prevalence and impact of the kit m541l variant in patients with mastocytosis | oncotarget
-
0:52
oncotarget: onc201, trail, and breast cancer
-
1:01
oncotarget | side effects of cancer treatments on learning, memory, genes
-
0:48
oncotarget: tumors, cortisol, relacorilant, and cytotoxic agents
-
1:39
tumor necroptosis promotes metastasis by modulating tumor-host immunity | oncotarget
-
0:41
oncotarget: combination therapeutics inhibit breast cancer resistance
-
3:19
what is immuno-oncology?
-
6:28
benefits of metronomic chemotherapy and the aims of the metronomic global health initiative
-
0:58
oncotarget | abt199/venetoclax in acute myeloid leukemia treatment
-
1:27
are cis-spliced fusion proteins pathological in more aggressive luminal breast cancer? | oncotarget
-
1:00:50
deciphering immuno-oncology: targeting innate immunity in cancer
-
56:52
pamela ohashi - immunoregulation and the tumor microenvironment
-
1:04
introducing the incucyte® live-cell analysis system: immunocytochemistry
-
0:27
immuno-oncology
-
0:57
anti-tumor immunity in the lymphoid microenvironment
-
3:35
cancer immunotherapy